Other
Carotid Plaque
0
Pipeline Programs↗
2
Active Trials↗
2
Companies Involved↗
Carotid Plaque is an early-stage landscape with 0 programs across 2 companies. The most active players are Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Pronova BioPharma.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
12
clinical trials
Completed5 · 42%
Unknown status3 · 25%
Terminated2 · 17%
Not yet recruiting2 · 17%
Clinical Trials
Trial Activity
12 trials
Effect of Small Interfering RNA Inclisiran on Carotid Plaques As Assessed by Carotid Ultrasound
Not yet recruiting·—·Phase 4·NCT06586684·40 enrolled
TRACER [F-18] RDG-K5 Carotid Plaque Imaging Study
Completed·—·Phase 2·NCT03364270·6 enrolled
Evaluation of Atorvastatin Treatment on Carotid Plaque.
Terminated·PPfizer's Upjohn has merged with Mylan to form Viatris Inc.·Phase 3·NCT00343655·160 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)